Re: Farmas USA
Quizas alguno conozca a abubnic de StockTwit.
Me ha mandado un mail sobre OMER. Me ha resultado extraño porque no es de las que hace eso y si me lo manda a mi entonces se lo ha mandado a los otros 50k seguidores que tiene ( 50k ! ) ... y eso ya me huele a intento de pumpeo en toda regla.
En cualquier caso, por si a alguno le interesa, ahi va lo recibido:
" Put some money in OMER. It popped today but it can still jump at least as much again, next week.
OMER was the victim of a hit piece in August and repeated bear raid attacks by large institutions. The price right now is still lower than their secondary offering at $22.75 last summer. So the stock is extremely undervalued. There are at least three catalysts very close ahead. Their earnings were excellent, but that's not really the story here. People think its about the surgical eye drops (Omiridia) but it isn't. Its the pipeline and what they are doing with monoclonal antibodies. They have breakthrough therapy status on OMS721 for treatment of severe kidney disease. The pipeline has other promises (OMS527) that can also do extraordinary things for treatment of all sorts of addictions. As one person says. proteinuria as an end point for OMS721 means buy anything under $50 and post-approval, anything under $100. I think they are absolutely right. I have 12,000 shares. I made $49,000 today and I'm not selling a dime of it. Too much good stuff ahead!
Definitely, listen to the webcast from Thursday night!
https://edge.media-server.com/m6/p/5ofemmz5
BTW, there are a lot of newbies on the ST stream, who didn't even know what this stock was two days ago. So ignore those who are cashing in already or saying to short it. There's a huge short float on this stock and that alone will propel it forward next week.
Check it out! - "
He subido a mi Google Drive el doc enviado de la ficha de los analistas de HainWright:
https://drive.google.com/open?id=1j2kkb42z0wU1Ua85vp-SX0ca3bnnTqyX
